Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00350857Phase 4Completed
A Phase 4 trial of carbamazepine in bipolar I disorder, sponsored by Validus Pharmaceuticals. Started Jul 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00350857.